Veracyte Price to Book Ratio 2012-2025 | VCYT
Historical price to book ratio values for Veracyte (VCYT) over the last 10 years. The current price to book ratio for Veracyte as of May 30, 2025 is 1.77.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Veracyte Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-30 | 26.61 | 1.74 | |
| 2025-03-31 | 29.65 | $15.26 | 1.94 |
| 2024-12-31 | 39.60 | $15.12 | 2.62 |
| 2024-09-30 | 34.04 | $15.18 | 2.24 |
| 2024-06-30 | 21.67 | $14.76 | 1.47 |
| 2024-03-31 | 22.16 | $14.64 | 1.51 |
| 2023-12-31 | 27.51 | $14.25 | 1.93 |
| 2023-09-30 | 22.33 | $14.44 | 1.55 |
| 2023-06-30 | 25.47 | $14.90 | 1.71 |
| 2023-03-31 | 22.30 | $14.94 | 1.49 |
| 2022-12-31 | 23.73 | $14.94 | 1.59 |
| 2022-09-30 | 16.60 | $14.61 | 1.14 |
| 2022-06-30 | 19.90 | $14.87 | 1.34 |
| 2022-03-31 | 27.57 | $15.19 | 1.81 |
| 2021-12-31 | 41.20 | $15.42 | 2.67 |
| 2021-09-30 | 46.45 | $15.59 | 2.98 |
| 2021-06-30 | 39.98 | $14.39 | 2.78 |
| 2021-03-31 | 53.75 | $14.49 | 3.71 |
| 2020-12-31 | 48.94 | $7.24 | 6.76 |
| 2020-09-30 | 32.49 | $7.31 | 4.44 |
| 2020-06-30 | 25.90 | $4.48 | 5.78 |
| 2020-03-31 | 24.31 | $4.61 | 5.28 |
| 2019-12-31 | 27.92 | $4.83 | 5.79 |
| 2019-09-30 | 24.00 | $4.73 | 5.07 |
| 2019-06-30 | 28.51 | $4.65 | 6.14 |
| 2019-03-31 | 25.02 | $2.02 | 12.40 |
| 2018-12-31 | 12.58 | $1.95 | 6.45 |
| 2018-09-30 | 9.55 | $1.96 | 4.87 |
| 2018-06-30 | 9.34 | $0.75 | 12.46 |
| 2018-03-31 | 5.56 | $0.87 | 6.36 |
| 2017-12-31 | 6.53 | $1.09 | 6.00 |
| 2017-09-30 | 8.77 | $1.26 | 6.96 |
| 2017-06-30 | 8.33 | $1.41 | 5.90 |
| 2017-03-31 | 9.18 | $1.58 | 5.83 |
| 2016-12-31 | 7.74 | $1.76 | 4.39 |
| 2016-09-30 | 7.61 | $1.07 | 7.09 |
| 2016-06-30 | 5.03 | $1.21 | 4.15 |
| 2016-03-31 | 5.40 | $1.55 | 3.47 |
| 2015-12-31 | 7.20 | $1.85 | 3.89 |
| 2015-09-30 | 4.69 | $2.09 | 2.24 |
| 2015-06-30 | 11.14 | $2.36 | 4.72 |
| 2015-03-31 | 7.28 | $1.56 | 4.68 |
| 2014-12-31 | 9.66 | $1.84 | 5.26 |
| 2014-09-30 | 9.75 | $2.15 | 4.54 |
| 2014-06-30 | 17.12 | $2.10 | 8.15 |
| 2014-03-31 | 17.13 | $2.38 | 7.21 |
| 2013-12-31 | 14.50 | $2.67 | 5.43 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.111B | $0.446B |
| Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.191B | 87.25 |
| Thermo Fisher Scientific (TMO) | United States | $152.413B | 18.44 |
| Edwards Lifesciences (EW) | United States | $45.596B | 29.90 |
| Alcon (ALC) | Switzerland | $42.592B | 28.78 |
| IDEXX Laboratories (IDXX) | United States | $41.462B | 47.65 |
| DexCom (DXCM) | United States | $33.274B | 51.43 |
| IQVIA Holdings (IQV) | United States | $24.396B | 13.66 |
| Mettler-Toledo (MTD) | United States | $24.382B | 29.00 |
| STERIS (STE) | Ireland | $24.071B | 26.54 |
| Waters (WAT) | United States | $21.144B | 29.83 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.666B | 0.00 |
| Hologic (HOLX) | United States | $14.021B | 15.23 |
| Sysmex ADR (SSMXY) | Japan | $10.468B | 29.70 |
| Penumbra (PEN) | United States | $10.283B | 80.71 |
| Masimo (MASI) | United States | $8.511B | 31.39 |
| Globus Medical (GMED) | United States | $7.972B | 19.00 |
| Glaukos (GKOS) | United States | $5.421B | 0.00 |
| Teleflex (TFX) | United States | $5.414B | 8.94 |
| TransMedics (TMDX) | United States | $4.319B | 93.89 |
| Integer Holdings (ITGR) | United States | $4.169B | 21.84 |
| PROCEPT BioRobotics (PRCT) | United States | $3.082B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.354B | 14.02 |
| Elekta AB (EKTAY) | Sweden | $2.106B | 18.93 |
| Nihon Kohden (NHNKY) | Japan | $2.054B | 23.56 |
| Alphatec Holdings (ATEC) | United States | $1.821B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.417B | 0.00 |
| Artivion (AORT) | United States | $1.269B | 118.84 |
| Pulse Biosciences (PLSE) | United States | $1.200B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.985B | 5.24 |
| SiBone (SIBN) | United States | $0.809B | 0.00 |
| IRadimed (IRMD) | United States | $0.739B | 37.51 |
| Beta Bionics (BBNX) | United States | $0.666B | 0.00 |
| RxSight (RXST) | United States | $0.660B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.594B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.09 |
| Mesa Laboratories (MLAB) | United States | $0.571B | 13.38 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.494B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.447B | 11.89 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.442B | 0.00 |
| NeuroPace (NPCE) | United States | $0.430B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.406B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.369B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.335B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.312B | 0.00 |
| Neuronetics (STIM) | United States | $0.260B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.94 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| 908 Devices (MASS) | United States | $0.210B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.182B | 0.00 |
| CVRx (CVRX) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| Accuray (ARAY) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.163B | 0.00 |
| LENSAR (LNSR) | United States | $0.162B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.148B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.138B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.098B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.70 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Spectral AI (MDAI) | United States | $0.042B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.37 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |